Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia

NCT00230659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-09-28

No results posted yet for this study

Summary

We will address coagulation parameters in hereditary haemorrhagic telangiectasia (HHT) compared to controls.

Conditions

  • Telangiectasia, Hereditary Hemorrhagic

Interventions

OTHER

Blood sample to be taken.

Blood sample to be taken.

Sponsors & Collaborators

  • Hammersmith Hospitals NHS Trust

    collaborator OTHER
  • Imperial College London

    lead OTHER

Principal Investigators

  • Claire Shovlin · Imperial College London

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2007-07-31
Completion
2008-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00230659 on ClinicalTrials.gov